Literature DB >> 6161207

Tumorigenicity and lysis by natural killers.

J L Collins, P Q Patek, M Cohn.   

Abstract

Detailed analysis of the natural killer (NK) activity directed at nontumorigenic cell lines and their transformed tumorigenic derivatives has revealed a paradox. On the one hand, a correlation has been found between the tumorigenic potential of chemically transformed fibroblast cell lines and their sensitivity to NK cells in vitro. Nontransformed cells (N-type cell lines) and cells tumorigenic in normal mice (C-type cell lines) are resistant to NK-mediated lysis. In contrast, cell lines that are tumorigenic in ATxFL mice (these mice are very low in NK activity), but not in normal mice (I-type cell lines) are sensitive to NK-mediated lysis. These findings support the concept that NK activity is involved in host surveillance against tumors. On the other hand, NK-resistant fibroblasts, whether taken directly form animals or derived as tumorigenic or nontumorigenic cell lines, compete with NK-sensitive target cells to inhibit their lysis by NK effectors. Not only are both NK-sensitive and -resistant cells recognized by NK effectors but both receive lytic signals from NK effector cells. Target cell resistance is a result of a protein synthesis-dependent mechanism that prevents lysis such that in the presence of inhibitors of protein synthesis all fibroblasts tested are NK sensitive. Those fibroblasts that are normally sensitive to NK-mediated lysis must be deficient in their ability to produce or respond to this counterlytic mechanism. These findings are in contrast with the general findings when lymphoid cells are studied as NK targets where sensitivity appears to be a result of recognition by NK effectors. Because our findings show that transformed and normal cells express the same recognition determinants, in order for NK activity to play an important in vivo role in tumor surveillance, a mechanism must operate to permit NK effectors to find their targets in vivo. In the absence of a special discrimination mechanism, the killing of NK-sensitive transformants that arise autochronously would be less than optimal as a consequence of competition by the normal, NK-resistant, cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161207      PMCID: PMC2186044          DOI: 10.1084/jem.153.1.89

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.

Authors:  L R Gooding
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

2.  T-cell inhibition of humoral responsiveness. I. Experimental evidence for restriction by the K- and/or D-end of the H-2 gene complex.

Authors:  R Epstein; M Cohn
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

3.  Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.

Authors:  C J Paige; E F Figarella; M J Cuttito; A Cahan; O Stutman
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

Review 4.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

5.  Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts.

Authors:  P S Hochman; G Cudkowicz
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

6.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

7.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Authors:  R B Herberman; M E Nunn; H T Holden; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

8.  "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

Authors:  R Kiessling; E Klein; H Pross; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

9.  Neurotransmitter synthesis by neuroblastoma clones (neuroblast differentiation-cell culture-choline acetyltransferase-acetylcholinesterase-tyrosine hydroxylase-axons-dendrites).

Authors:  T Amano; E Richelson; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Decline of natural killer cell activity in sublethally irradiated mice.

Authors:  P S Hochman; G Cudkowicz; J Dausset
Journal:  J Natl Cancer Inst       Date:  1978-07       Impact factor: 13.506

View more
  33 in total

1.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.

Authors:  Bimal K Chakrabarti; Wing-pui Kong; Bei-yue Wu; Zhi-Yong Yang; Jacques Friborg; Xu Ling; Steven R King; David C Montefiori; Gary J Nabel
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor.

Authors:  Y Lin; P G Case; P Q Patek
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 4.  The common sense of the self-nonself discrimination.

Authors:  Melvin Cohn
Journal:  Springer Semin Immunopathol       Date:  2005-02-15

5.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Antimetastatic effect of defibrinogenation with batroxobin depends on the natural killer activity of host in mice.

Authors:  M Shibuya; H Niitani; A Aoyama; S Kawachi; N Nukariya; M Baba; K Iizuka; S Sakai; M Ohtsuka
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

7.  Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin.

Authors:  C B Powell; D G Mutch; M S Kao; J L Collins
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

8.  The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

Authors:  J L Collins; M S Kao
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  The in vivo clearance of Ha-ras transformants by natural killer cells.

Authors:  P W Johnson; J Stankova; D Dexter; J C Roder
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

10.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.